Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate in CAD patients with DM or CKD
NCT02294643Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sarpogrelate in coronary artery disease (CAD), sponsored by Seoul National University Bundang Hospital. Started Apr 2009; status: completed.
02
Drugs
sarpogrelate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02294643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294643.